Article
The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2020
Huang Manling, He Minghui, Guo Yu, Li Heping, Shen Shunli, Xie Yubin, Li Xiaoxing, Xiao Han, Fang Lujing, Li Dongming, Peng Baogang, Liang Lijian, Yu Jun, Kuang Ming, Xu Lixia, Peng Sui
Abstract excerpt
PURPOSE: Immune checkpoint inhibitor therapy is emerging as the promising option for patients with advanced hepatocellular carcinoma. We aimed to investigate the heterogeneity of different tumor nodules of the same patient with multifocal hepatocellular carcinomas in response to immunotherapy and its molecular mechanisms. EXPERIMENTAL DESIGN: We attained 45 surgical tumor samples including 33 small and 12 large...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
